Balyasny Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,373
| Closed | -$297K | – | 2253 |
|
|
2025
Q1 | $297K | Buy |
13,373
+452
| +3% | +$10K | ﹤0.01% | 1709 |
|
|
2024
Q4 | $256K | Buy |
+12,921
| New | +$256K | ﹤0.01% | 1684 |
|
|
2024
Q2 | – | Sell |
-26,200
| Closed | -$517K | – | 2186 |
|
|
2024
Q1 | $517K | Sell |
26,200
-20,089
| -43% | -$396K | ﹤0.01% | 1464 |
|
|
2023
Q4 | $812K | Buy |
+46,289
| New | +$812K | ﹤0.01% | 1271 |
|
|
2023
Q1 | – | Sell |
-2,695
| Closed | -$40.4K | – | 2433 |
|
|
2022
Q4 | $40.4K | Buy |
+2,695
| New | +$40.4K | ﹤0.01% | 1936 |
|
|
2021
Q3 | – | Sell |
-400,296
| Closed | -$5.58M | – | 1896 |
|
|
2021
Q2 | $5.58M | Buy |
+400,296
| New | +$5.58M | 0.03% | 602 |
|